Want to see SE:AINO full AI Analyst Report?

Aino Health AB (AINO) Price & Analysis

0 Followers

AINO Stock Chart & Stats

kr0.18

-kr0.04(-22.87%)

At close: Mar 06 4:00 PM EST

kr0.18

-kr0.04(-22.87%)

Day’s Range― - ―

52-Week Rangekr0.11 - kr0.29

Previous CloseN/A

Volume5.00K

Average Volume (3M)34.66K

Market Cap

kr48.28M

Enterprise Valuekr45.75

Total Cash (Recent Filing)kr1.92M

Total Debt (Recent Filing)kr7.98M

Price to Earnings (P/E)―

Beta1.18

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.05

Shares Outstanding204,569,100

10 Day Avg. Volume35,299

30 Day Avg. Volume34,661

Financial Highlights & Ratios

PEG Ratio0.10

Price to Book (P/B)-5.45

Price to Sales (P/S)1.34

P/FCF Ratio-14.49

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Digital Health Business ModelAino operates in a structurally relevant digital health segment, helping employers manage absenteeism and work ability through data-driven processes. Software access combined with implementation and support services can create repeatable customer relationships and position the company within an ongoing workplace-health need.

Loss Reduction Versus 2022The substantial improvement in net margin from 2022 indicates that losses have narrowed over time, even though the company remains unprofitable. If this direction can continue, it could reduce the funding burden and provide a foundation for eventual operating leverage as revenue stabilizes.

Improved Cash Burn Versus 2022Operating cash consumption is materially lower than in 2022, showing some progress in cash discipline over the longer period. Although cash flow remains negative and worsened versus 2025, the reduction from earlier burn levels could support a gradual path toward improved financial sustainability.

Bears Say

Revenue ContractionRevenue contraction indicates that the company is not currently demonstrating dependable top-line expansion, which limits its ability to absorb fixed costs and invest in growth. A shrinking revenue base also makes it harder for the software and services model to reach sustainable operating scale.

Deep Operating LossesDeeply negative operating and net margins show that the current business is far from self-funding, despite reported improvement from earlier periods. Persistent losses can constrain investment, weaken negotiating flexibility, and require management to prioritize restructuring or profitability measures over expansion.

Negative Equity And Thin Capital BaseNegative equity and debt exceeding total assets indicate a severely weakened capital structure and limited financial flexibility. This raises refinancing and funding risk if losses continue, while the thin asset base reduces the company’s ability to absorb setbacks or finance operations without external support.

AINO FAQ

What was Aino Health AB’s price range in the past 12 months?

Aino Health AB lowest stock price was kr0.11 and its highest was kr0.29 in the past 12 months.

What is Aino Health AB’s market cap?

Aino Health AB’s market cap is kr48.28M.

When is Aino Health AB’s upcoming earnings report date?

Aino Health AB’s upcoming earnings report date is Nov 12, 2026 which is in 48 days.

How were Aino Health AB’s earnings last quarter?

Aino Health AB released its earnings results on Aug 17, 2026. The company reported -kr0.013 earnings per share for the quarter.

Is Aino Health AB overvalued?

According to Wall Street analysts Aino Health AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Aino Health AB pay dividends?

Aino Health AB does not currently pay dividends.

What is Aino Health AB’s EPS estimate?

Aino Health AB’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Aino Health AB have?

Aino Health AB has 204,569,100 shares outstanding.

What happened to Aino Health AB’s price movement after its last earnings report?

Aino Health AB reported an EPS of -kr0.013 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Aino Health AB?

Currently, no hedge funds are holding shares in SE:AINO

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Aino Health AB

Aino Health AB (publ), a Swedish company based in Stockholm, specializes in delivering comprehensive corporate health management solutions to both private and public organizations throughout Finland. Their flagship offering is HealthManager, a Software-as-a-Service (SaaS) platform equipped with tools for health surveys, analytical insights, exposure checks, and compliance with security and GDPR regulations, along with an integrated e-learning module. Beyond the software, Aino Health provides a range of additional services, including telemedicine, professional support (such as analytics, management/employee guidance, and well-being programs), and onboarding assistance covering project management, implementation, and training. The company also extends its services to a diverse network of partners, including occupational health providers, insurance companies, IT firms, HR/payroll service centers, and various healthcare practitioners.